A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Completed · Not applicable

Conditions studied: HIV Infections

In brief

To evaluate the tolerance, and comparative virologic and immunologic effects of the two combination regimens.

Key facts

Study ID

NCT00002369

Run by

Bristol-Myers Squibb

People needed

200

Last updated by the study team

2007-10-02

Who can join

Age: 16 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must have:
• Documented HIV infection.
• CD4 cell count of 200 - 700 cells/mm3.

You may not qualify if…

• Co-existing Condition:
• Patients with the following symptoms or conditions are excluded:
• AIDS defining condition within 1 month of study entry.
• Prior Medication:
• Excluded:
• Patients with any history of antiretroviral therapy treatment.

Where it is running

• Univ of Alabama at Birmingham — Birmingham, Alabama, United States
• HIV Clinical Research Ctr — Fort Lauderdale, Florida, United States
• Infectious Disease Research Institute Inc — Tampa, Florida, United States
• Advance Clinical Research — Atlanta, Georgia, United States
• Louisiana State Univ Med Ctr / HIV Outpatient Clinic — New Orleans, Louisiana, United States
• Boston Univ Med Ctr Hosp / Evans - 556 — Boston, Massachusetts, United States
• Community Research Initiative of New England — Brookline, Massachusetts, United States
• Washington Univ School of Medicine — St Louis, Missouri, United States
• Blackstock Family Health Ctr — Austin, Texas, United States
• Hosp Regional de Ponce - Area Vieja — Ponce, Puerto Rico
• San Juan AIDS Program — Santurce, Puerto Rico

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.